This inventor holds 1 USPTO granted patent. Top assignee: Janssen Pharmaceutica Nv. Active years: 1999.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1999
Title: Inventor Spotlight: Petrus Franciscus Van De Plas
Introduction
Petrus Franciscus Van De Plas is a notable inventor based in Breda, Netherlands, with a specialization in detection systems. His innovation has led to the development of a unique technology capable of detecting bindable substances in living materials, marking a significant advancement in analytical methods.
Latest Patents
Van De Plas holds one patent, titled "Universally Applicable Detection System Based on Ultra Small Colloidal." This invention describes an aggregate designed to qualitatively or quantitatively determine bindable substances. The aggregate includes an ultra-small colloidal particle with a mean diameter of less than 2 nm and a specific binding agent. This size allows the aggregate to penetrate standard biological specimens, enhancing the potential for various applications in medical diagnostics and research.
Career Highlights
Petrus Franciscus Van De Plas is associated with Janssen Pharmaceutica NV, a renowned pharmaceutical company known for its commitment to innovation in healthcare. His contributions in this capacity showcase his expertise and dedication to advancing scientific understanding through practical applications of his inventions.
Collaborations
Throughout his career, Van De Plas has collaborated with esteemed professionals such as Johannes Leonardus Leunissen and Marc Joris De Brabander. These partnerships highlight the collaborative nature of scientific research and innovation, where teamwork often leads to groundbreaking discoveries.
Conclusion
Petrus Franciscus Van De Plas stands out as an influential inventor whose work in detection systems showcases the intersection of technology and biology. His contributions not only enhance our capabilities in identifying essential biological substances but also pave the way for future advancements in medical research and diagnostics.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
